Skin News and Research

RSS

Using a fan to cool down can worsen allergies like hayfever

Britain is facing a heat wave this week with maximum temperatures hovering around 34C. This heat may make sleeping comfortably at night difficult. To combat the heat many people turn on their fans to cool down as they sleep. Mark Reddick, wrote for Sleep Advisor and explained how the use of the fans at night can have a negative impact on health.

27 Jul 2018

People with skin of color experience a variety of skin conditions

Although skin disease can affect anyone, it may not affect everyone in the same way - and this is especially true for patients with skin of color.

26 Jul 2018

Early detection plays big role in nail melanoma prognosis

Karolina Jasko's nails were usually painted during her senior year of high school, so she didn't notice the black vertical line on her right thumbnail until a nail technician pointed it out - and at the time, she didn't think much of it.

26 Jul 2018

Organ transplant patients have higher risk for skin cancer

While anyone can develop skin cancer, regardless of age, race or gender, certain groups of people have a higher risk of getting the disease than others.

26 Jul 2018

New research highlights value of free skin cancer screening program

While skin cancer can be deadly, it is also highly treatable when detected early. In fact, melanoma, the deadliest form of skin cancer, has a five-year survival rate of 95 percent when detected and treated before it spreads to the lymph nodes; conversely, the five-year survival rates for regional and distant stage melanomas are 64 percent and 23 percent, respectively.

26 Jul 2018

CNDA approves KEYTRUDA for treatment of advanced melanoma

Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.

26 Jul 2018

New drug offers hope to prevent attacks of hereditary angioedema

Hereditary angioedema is a chronic disorder that can sometimes be life-threatening. Now, a new drug therapy has been successfully tested in an international study headed by the University Hospital Frankfurt.

26 Jul 2018

$Researcher reveals new way to stimulate bone fracture healing$

Researcher reveals new way to stimulate bone fracture healing

Most people have broken a bone or know someone who has. A break is painful and takes time to heal. Recovering from a fracture is even more complicated and lengthy when your body is not able to produce what is needed to heal.

26 Jul 2018

Adherence to Mediterranean diet may be linked to severity in psoriasis

Adherence to a Mediterranean diet, an eating plan filled with fruits and vegetables, legumes, cereals, bread, fish, fruit, nuts and extra-virgin olive oil, may be associated with the severity of the skin condition psoriasis.

26 Jul 2018

Researchers assess characteristics and skin cancer risk behaviors of sunless tanners

Many advertisements, articles and reports make bold statements regarding sunless tanning products - sprays, ointments, creams, foams, or lotions that promise tan skin without the increased risk of skin cancer that goes along with outdoor sunbathing or indoor tanning

26 Jul 2018

Disrupted transportation routes in nerve cells are main cause of Parkinson's disease

'Traffic jams' can also occur in the brain and they can be damaging. Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg have been able to confirm that this is the case.

26 Jul 2018

Study reveals key role of actin cytoskeletal dynamics in supporting immune cell function

In order to move, a body needs a strong scaffold. This is not only true on a macroscopic level, where animals rely on skeletons to support their muscles.

26 Jul 2018

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck, known as MSD outside the United States and Canada, announced today that the pivotal Phase 3 KEYNOTE-048 trial investigating KEYTRUDA, Merck's anti-PD-1 therapy, for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma, met a primary endpoint of overall survival as monotherapy in patients whose tumors expressed PD-L1.

25 Jul 2018

Physician discusses role of telehealth in disaster response

Telehealth, the use of TV and computer monitors to deliver healthcare remotely, is proving to be a valuable addition to many practices.

25 Jul 2018

Researchers study whole genome sequences of human induced pluripotent stem cells

The therapeutic potential of human induced pluripotent stem cells, which are capable of becoming almost any type of cell in the human body, is well-recognized and broadly pursued, but their mutational burden has not been fully characterized yet.

25 Jul 2018

Mutational burden of stem cells studied to improve disease models and therapies

Researchers from the University of California have characterized the mutational burden of human induced pluripotent stem cells (iPSCs), potentially improving researchers’ ability to prioritize stem cell lines for models of human disease and/or therapies.

25 Jul 2018